Results 11 to 20 of about 33,041 (261)
CD20 deficiency in humans results in impaired T cell-independent antibody responses. [PDF]
, 2010 CD20 was the first B cell differentiation antigen identified, and CD20-specific mAbs are commonly used for the treatment of B cell malignancies and autoantibody-mediated autoimmune diseases.
Bende, R.J. +40 more
core +1 more source
FMC7 antigen expression on normal and malignant B-cells can be predicted by expression of CD20 [PDF]
Cytometry, 1998 Most antibody panels proposed for flow cytometric immunophenotyping of non-Hodgkin's lymphomas and chronic lymphoid leukemias include anti-CD20 and FMC7 antibodies. As in our experience, reactivity of B-cells with these antibodies seemed to be correlated, we evaluated whether the simultaneous use of anti-CD20 and FMC7 antibodies is justified.
W, Hübl, J, Iturraspe, R C, Braylan
openaire +2 more sources
, 2009 Anti-malarial antibody responses represent an individual's history of exposure to the disease and, as age sero-conversion rates, reflect cumulative malaria exposure in a population.
Jackie Cook +3 more
core +1 more source
, 2022 Anti-CD20 therapies decrease the humoral response to SARS-CoV-2 immunization. We aimed to determine the extent of the humoral response to SARS-CoV-2 antigens in correlation with peripheral B-cell dynamics among patients with central nervous system ...
Seiberl, Michael +23 more
core +1 more source
Disease progression after R-CHOP treatment associated with the loss of CD20 antigen expression [PDF]
Revista Brasileira de Hematologia e Hemoterapia, 2010 A case of a follicular lymphoma transformed into a CD20(+) is described which progressed with the loss of CD20 expression after 8 cycles of R-CHOP. This phenomenon is not a rare event and has shown poor prognosis. Our purposes are to describe this event and suggest biopsy in relapsed or progressive disease.
Marcelo Bellesso +5 more
openaire +3 more sources
Detection of the T cell antigens CD3 and CD4 on CD20+ lymphocytes by flow cytometry.
, 2014 The appearance of both CD3 (A) and CD4 antigens (B) on the surface of CD20+ lymphocytes is shown for one representative patient. Freshly isolated lymphocytes (left) were compared to lymphocytes analyzed after overnight (oN) storage of whole blood samples
Heinz Wiendl (237353) +5 more
core +1 more source
CD20 (Pan-B Cell Antigen) Expression on Bone Marrow-Derived T Cells [PDF]
American Journal of Clinical Pathology, 1996 Antibodies directed against CD20 (L26, Leu 16, and B1) are frequently used to determine the presence of B lymphocytes. However, recent publications describe the unexpected presence of CD20-positive T cells in the peripheral blood of normal subjects and occasional T-cell neoplasms that express CD20.
K M, Algino +4 more
openaire +2 more sources
Development of Stable CHO-K1 Cell Lines Overexpressing Full Length Human CD20 Antigen
Iranian Biomedical Journal, 2023 CD20 is a differentiation-related antigen exclusively expressed on the membrane of B lymphocytes. CD20 amplification is observed in numerous immune-related disorders, making it an ideal target for immunotherapy of hematological malignancies and autoimmune diseases.
Mohammadkhani, Niloufar +3 more
openaire +2 more sources
Antibody against CD20 in patients with B cell malignancy
, 2001 Cancer patients may make antibodies against antigens on the surface of their malignant cells due either to the expression of unique antigens or to dysregulated responses to self antigens.
Zola, H. +9 more
core +1 more source
Flow cytometry detection of TV antigens-containing cells in vitro.
, 2012 A– PBMCs isolated from healthy rhesus macaques were used for in vitro inoculation with TV. After being cultured in vitro for 6 days, cells were sorted out into CD3+ T cell and CD20+ B cell populations.
Bapi Pahar (33183) +9 more
core +1 more source